The ZAXL:239 affibody significantly reduced cell viability and inhibited tumor proliferation by inhibiting the phosphorylation levels of the PI3K/AKT1 and MEK/ERK pathway in mice model. The gene discussed is AKT1; the disease is neoplasm.